Bolt Biotherapeutics Ownership | Who Owns Bolt Biotherapeutics?
Bolt Biotherapeutics Ownership Summary
Bolt Biotherapeutics is owned by 2.32% institutional investors, 2.26% insiders, and 95.42% retail investors. Citadel advisors is the largest institutional shareholder, holding 6.22% of BOLT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.46% of its assets in Bolt Biotherapeutics shares.
BOLT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Bolt Biotherapeutics | 2.32% | 2.26% | 95.42% |
| Sector | Healthcare Stocks | 487.91% | 11.08% | -398.99% |
| Industry | Biotech Stocks | 307.10% | 11.11% | -218.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Citadel advisors | 2.37M | 6.22% | $1.78M |
| Blackrock | 267.07K | 0.70% | $200.30K |
| Fmr | 129.25K | 0.34% | $69.16K |
| Morgan stanley | 33.69K | 0.09% | $25.27K |
| Bank of america corp /de/ | 628.00 | 0.00% | $471.00 |
| Newedge advisors | 483.00 | 0.00% | $2.79K |
| Salem investment counselors | 2.00 | 0.00% | $11.00 |
| Renaissance | - | - | - |
| Susquehanna group, llp | - | - | - |
| Engineers gate manager lp | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Citadel advisors | 2.37M | 0.00% | $1.78M |
| Renaissance | - | - | - |
| Tower research capital llc (trc) | - | - | - |
| Engineers gate manager lp | - | - | - |
| Blackrock | 267.07K | - | $200.30K |
| Salem investment counselors | 2.00 | - | $11.00 |
| Mariner | - | - | - |
| Two sigma securities | - | - | - |
| Susquehanna group, llp | - | - | - |
| Prudential financial | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 129.25K | - | 13.87K |
| Blackrock | 267.07K | - | 12.11K |
| Morgan stanley | 33.69K | - | 9.00K |
| Newedge advisors | 483.00 | - | 483.00 |
| Salem investment counselors | 2.00 | - | - |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tang capital management | - | - | -3.81M |
| Vivo capital | - | - | -3.52M |
| Sofinnova investments | - | - | -2.75M |
| Pivotal bioventure partners investment advisor | - | - | -1.89M |
| Orbimed advisors | - | - | -1.54M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Newedge advisors | 483.00 | - | 483.00 | $2.79K |
Sold Out
| Holder | Change |
|---|---|
| Bnp paribas arbitrage, snc | -1.00 |
| Qube research | -2.00 |
| Wells fargo & company/mn | -211.00 |
| Jpmorgan chase | -906.00 |
| Steward partners investment advisory | -1.00K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 24 | -14.29% | 889,879 | -95.14% | 2 | 40.64% | 2 | -80.00% | 22 | 340.00% |
| Mar 31, 2025 | 28 | -24.32% | 18,325,858 | -1.84% | 47 | 2.01% | 10 | -41.18% | 5 | - |
| Dec 31, 2024 | 37 | 19.35% | 18,670,034 | -0.60% | 48 | 2.02% | 17 | 70.00% | 5 | -37.50% |
| Sep 30, 2024 | 31 | -11.43% | 18,782,187 | -16.99% | 49 | 1.39% | 10 | -37.50% | 8 | 33.33% |
| Jun 30, 2024 | 35 | -5.41% | 22,625,732 | -5.73% | 59 | 1.48% | 16 | 60.00% | 6 | -45.45% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 47.18K | 2.46% | -1.03K |
| Vanguard US Total Market Shares ETF | 861.87K | 2.25% | -1.00 |
| Vanguard Institutional Extnd Mkt Idx Tr | 7.06K | 0.37% | -3.22K |
| Fidelity Extended Market Index | 7.00K | 0.36% | -49.00 |
| Fidelity Total Market Index | 5.38K | 0.28% | - |
| Fidelity Enhanced Small Cap ETF | 90.25K | 0.24% | 1.69K |
| Spartan Extended Market Index Pool F | 3.06K | 0.16% | 49.00 |
| Bridgeway Ultra-Small Company Market | 60.20K | 0.16% | - |
| Spartan Extended Market Index Pool E | 58.62K | 0.15% | 1.23K |
| PGIM Quantitative Solutions US Micro Cap | 2.38K | 0.12% | 2.38K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 06, 2025 | Nemec Sarah | Senior VP, Finance and PAO | Buy | $686.50 |
| Jun 06, 2025 | Quinn William P. | President, CEO and CFO | Buy | $686.50 |
| Jun 06, 2024 | Nemec Sarah | Senior VP, Finance and PAO | Buy | $1.59K |
| Dec 16, 2024 | Nemec Sarah | Senior VP, Finance and PAO | Buy | $1.24K |
| Dec 16, 2024 | Quinn William P. | President, CEO and CFO | Buy | $1.24K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | - |
| 2025 Q2 | 2 | - |
| 2024 Q4 | 2 | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
BOLT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools